Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hyperthermia 6 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pelvic Pain 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Liver Neoplasms 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Agnosia 1 Acute Pain 1

Interventions

Bupivacaine 4 Saline Solution 3 Ketamine 3 Transcutaneous Electric Nerve Stimulation 2 Ropivacaine 2 Radiofrequency Ablation 2 Magnesium Sulfate 2 Ketorolac 2 Dexmedetomidine 2 Control Groups 2 Anesthesia, Local 2 Acupuncture Therapy 2 Acetaminophen 2 engage 8200 1 Yoga 1 Varenicline 1 Transdermal Patch 1 Therapeutics 1 Telemedicine 1 Surgical Instruments 1 STAMP-I protocol 1 Radiosurgery 1 Psilocybin 1 Palliative Care 1 Oxycodone 1 Music Therapy 1 Morphine 1 Methods 1 Levobupivacaine 1 Ketoprofen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Agnosia × Diathermy × 1 year × Clear all

NCT04778631 2025-11-20

PERISAFE

Assistance Publique - Hôpitaux de Paris

Phase NA Completed

Hyperthermia, Agnosia, Neoplasm Metastasis, Pelvic Pain, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡